Brief: Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule
28/01/2026 21:28
Jan 28 (Reuters) - Contineum Therapeutics Inc CTNM.O: CONTINEUM THERAPEUTICS REPORTS INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4) Source text: ID:nBw7qXyf7a Further company coverage: CTNM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Contineum Therapeutics
See all newsPREVIEW: Johnson & Johnson earnings expected to decline in Q3
PREVIEW: Johnson & Johnson earnings expected to decline in Q3
US STOCKS ON THE MOVE-Microsoft, Salesforce, Bristol Myers
US STOCKS ON THE MOVE-Microsoft, C3.ai, Salesforce, Bristol Myers
Contineum tumbles as Bristol's partial trial win raises dose doubts